0
  • Growth Hormone Secretagogue

Tesamorelin

FDA-labelled 2 mg daily for HIV-associated visceral fat (Egrifta). Raises IGF-1.

What it does / how it works

A stabilised full-length GHRH analogue. Daily use raises GH and IGF-1 and is labelled to cut visceral fat in HIV lipodystrophy. Not a substitute for injecting HGH itself.

Class Stabilised GHRH analogue
Typical vial 5 / 10 / 20 mg
Reconstitution BAC water for research vials
Storage after mix 2–8°C, use within 28 days

Protocol

Goal Dose How often How long Route
Original Egrifta trials 2 mg Once daily 26 weeks SubQ abdomen
Current US label Egrifta SV 1.4 mg Once daily Ongoing labelled use SubQ abdomen
Reassess Hold if IGF-1 high Daily or stop After 8-26 weeks –

Watch: A 10 mg vial at the labelled 2 mg dose is 5 days. WADA prohibited.

Tesamorelin FAQ — Australia

ELV8 Labs offers Tesamorelin in 10 mg vials, third-party tested at a leading Australian university. For research purposes only.
Tesamorelin is the most clinically validated GHRH analogue, with Phase III trial data. It uses the full 44-amino-acid GHRH sequence (vs 29 for Sermorelin and CJC-1295). Its primary research differentiation is published data on visceral fat reduction, which other GHRH analogues lack at the same evidence level.
Tesamorelin’s higher molecular weight (5,135 g/mol) and the dosing established in clinical trials (2 mg daily) result in milligram-level dosing. This is similar to TB-500 and reflects the molar concentrations used in the original published research.
While less commonly documented than the CJC-1295 + Ipamorelin combination, Tesamorelin can be combined with GHRPs like Ipamorelin to target both GHRH and GHRP pathways. This combination approach is referenced in some Australian research protocols.
While less commonly documented than the CJC-1295 + Ipamorelin combination, Tesamorelin can be combined with GHRPs like Ipamorelin to target both GHRH and GHRP pathways. This combination approach is referenced in some Australian research protocols.

Recommended Supplier — Tesamorelin Australia

Our products offer premium-grade research materials with independent testing at a leading Australian university. Every batch is strictly verified by RP-HPLC and LC-MS. For research purposes only.

View Tesamorelin — ELV8 Labs

Related Research — Australia

Explore similar research-grade peptides, selected to complement your research needs.

All Protocols
  • Growth Hormone Secretagogue

Tesamorelin + Ipamorelin

Tesamorelin target is 1-2 mg daily. Ipamorelin target....
View protocol
  • Performance & Athletic Research

Super Human Blend

One serving: L-Arginine 110 mg, L-Ornithine 110 mg,....
View protocol
  • Cognitive & Neurological

Semax + Selank

Short course. Intranasal preferred. Then 2-4 weeks off.....
View protocol
  • Fat Loss And Metabolic

Retatrutide + Cagrilintide

5+5 mg is a late stock, not a....
View protocol
Select your currency
USD United States (US) dollar
AUD Australian dollar
My Account
Peptide Catalogs
Follow Us
Linkedin X-twitter Facebook-square